Kumra Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.20 M
as on 23-10-2024
- Company Age 29 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 644.52%
(FY 2023)
- Profit 111.59%
(FY 2023)
- Ebitda 147.96%
(FY 2023)
- Net Worth 0.37%
(FY 2023)
- Total Assets 10.21%
(FY 2023)
About Kumra Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.20 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Kumra, Monika Kumra, and Arjun Kumra serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PTC074702
- Company No.
074702
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kumra Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Kumra  | Director | 18-Dec-1995 | Current |
| Monika Kumra | Director | 18-Dec-1995 | Current |
| Arjun Kumra | Director | 28-Nov-2016 | Current |
Financial Performance of Kumra Pharma.
Kumra Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 644.52% increase. The company also saw a substantial improvement in profitability, with a 111.59% increase in profit. The company's net worth moved up by a moderate rise of 0.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kumra Pharma?
In 2023, Kumra Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karmed Lifesciences Private LimitedActive 3 years 5 monthsAtul Kumra, Monika Kumra and 1 more are mutual person
Medicine House Worldwide Pharmaceuticals Private LimitedActive 9 years 2 monthsAtul Kumra and Arjun Kumra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kumra Pharma?
Unlock and access historical data on people associated with Kumra Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kumra Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kumra Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
